Influence of maternal antibodies on active pertussis toxoid immunization of neonatal mice and piglets

Vaccine

Volumn 29, Issue 44, 2011, Pages 7718-7726

  Polewicz, Monika ^a   Gracia, Aleksandra ^a   Buchanan, Rachelle ^a   Strom, Stacy ^a   Halperin, Scott A ^c   Potter, Andrew A ^a   Babiuk, Lorne A ^d   Gerdts, Volker ^a,b  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

^c DALHOUSIE UNIVERSITY   (Canada)

^d UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Interference with maternal antibodies; Maternal antibodies; Neonatal vaccines; Pertussis

Indexed keywords

IMMUNOLOGICAL ADJUVANT; MATERNAL ANTIBODY; PERTUSSIS TOXOID; PERTUSSIS VACCINE; UNCLASSIFIED DRUG;

ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; ARTICLE; BAGG ALBINO MOUSE; CONTROLLED STUDY; DRUG COMPETITION; DRUG DETOXIFICATION; FEMALE; MALE; MOUSE; NEWBORN; NONHUMAN; PERTUSSIS; PIGLET; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANIMALS, NEWBORN; ANTIBODIES, BACTERIAL; FEMALE; IMMUNITY, MATERNALLY-ACQUIRED; IMMUNIZATION; IMMUNIZATION, SECONDARY; MALE; MICE; MICE, INBRED BALB C; PERTUSSIS VACCINE; SWINE; TOXOIDS; WHOOPING COUGH;

EID: 80053614460     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.07.135     Document Type: Article

References (59)

1. Mattoo S., Cherry J.D. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 2005, 18(April (2)):326-382.
2. Pertussis vaccines. Wkly Epidemiol Rec 1999, 74(May (18)):137-143.
3. Ivanoff B., Robertson S.E. Pertussis: a worldwide problem. Dev Biol Stand 1997, 89:3-13.
4. Crowcroft N.S., Pebody R.G. Recent developments in pertussis. Lancet 2006, 367(June (9526)):1926-1936.
5. Vitek C.R., Pascual F.B., Baughman A.L., Murphy T.V. Increase in deaths from pertussis among young infants in the United States in the 1990s. Pediatr Infect Dis J 2003, 22(July (7)):628-634.
6. Tanaka M., Vitek C.R., Pascual F.B., Bisgard K.M., Tate J.E., Murphy T.V. Trends in pertussis among infants in the United States, 1980-1999. JAMA 2003, 290(December (22)):2968-2975.
7. Ntezayabo B., De Serres G., Duval B. Pertussis resurgence in Canada largely caused by a cohort effect. Pediatr Infect Dis J 2003, 22(January (1)):22-27.
8. Healy C.M., Munoz F.M., Rench M.A., Halasa N.B., Edwards K.M., Baker C.J. Prevalence of pertussis antibodies in maternal delivery, cord, and infant serum. J Infect Dis 2004, 190(July (2)):335-340.
9. Forsyth K.D., Campins-Marti M., Caro J., Cherry J.D., Greenberg D., Guiso N., et al. New pertussis vaccination strategies beyond infancy: recommendations by the global pertussis initiative. Clin Infect Dis 2004, 39(December (12)):1802-1809.
10. Skowronski D.M., De Serres G., MacDonald D., Wu W., Shaw C., Macnabb J., et al. The changing age and seasonal profile of pertussis in Canada. J Infect Dis 2002, 185(May (10)):1448-1453.
11. Wendelboe A.M., Njamkepo E., Bourillon A., Floret D.D., Gaudelus J., Gerber M., et al. Transmission of Bordetella pertussis to young infants. Pediatr Infect Dis J 2007, 26(April (4)):293-299.
12. Theilen U., Johnston E.D., Robinson P.A. Rapidly fatal invasive pertussis in young infants-how can we change the outcome?. BMJ 2008, 337:a343.
13. Wood N., McIntyre P. Pertussis: review of epidemiology, diagnosis, management and prevention. Paediatr Respir Rev 2008, 9(September (3)):201-211. quiz 11-2.
14. Tan T., Halperin S., Cherry J.D., Edwards K., Englund J.A., Glezen P., et al. Pertussis immunization in the global pertussis initiative North American region: recommended strategies and implementation considerations. Pediatr Infect Dis J 2005, 24(May (5 Suppl.)):S83-S86.
15. Pertussis deaths-United States, 2000. MMWR Morb Mortal Wkly Rep 2002, 51(July (28)):616-618.
16. Pertussis-United States, 1997-2000. MMWR Morb Mortal Wkly Rep 2002, 51(February (4)):73-76.
17. Van Rie A., Wendelboe A.M., Englund J.A. Role of maternal pertussis antibodies in infants. Pediatr Infect Dis J 2005, 24(May (5 Suppl.)):S62-S65.
18. Edwards K.M. Pertussis: an important target for maternal immunization. Vaccine 2003, 21(July (24)):3483-3486.
19. Mooi F.R., de Greeff S.C. The case for maternal vaccination against pertussis. Lancet Infect Dis 2007, 7(September (9)):614-624.
20. Osborn J.J., Dancis J., Julia J.F. Studies of the immunology of the newborn infant. II. Interference with active immunization by passive transplacental circulating antibody. Pediatrics 1952, 10(September (3)):328-334.
21. Glezen W.P. Effect of maternal antibodies on the infant immune response. Vaccine 2003, 21(July (24)):3389-3392.
22. Siegrist C.A., Cordova M., Brandt C., Barrios C., Berney M., Tougne C., et al. Determinants of infant responses to vaccines in presence of maternal antibodies. Vaccine 1998, 16(August-September (14-15)):1409-1414.
23. Albrecht P., Ennis F.A., Saltzman E.J., Krugman S. Persistence of maternal antibody in infants beyond 12 months: mechanism of measles vaccine failure. J Pediatr 1977, 91(November (5)):715-718.
24. Crowe J.E. Influence of maternal antibodies on neonatal immunization against respiratory viruses. Clin Infect Dis 2001, 33(November (10)):1720-1727.
25. Daum R.S., Siber G.R., Ballanco G.A., Sood S.K. Serum anticapsular antibody response in the first week after immunization of adults and infants with the Haemophilus influenzae type b-Neisseria meningitidis outer membrane protein complex conjugate vaccine. J Infect Dis 1991, 164(December (6)):1154-1159.
26. Kanra G., Yalcin S.S., Ceyhan M., Yurdakok K. Clinical trial to evaluate immunogenicity and safety of inactivated hepatitis A vaccination starting at 2-month-old children. Turk J Pediatr 2000, 42(April-June (2)):105-108.
27. Karron R.A., Steinhoff M.C., Subbarao E.K., Wilson M.H., Macleod K., Clements M.L., et al. Safety and immunogenicity of a cold-adapted influenza A (H1N1) reassortant virus vaccine administered to infants less than six months of age. Pediatr Infect Dis J 1995, 14(January (1)):10-16.
28. Sarvas H., Kurikka S., Seppala I.J., Makela P.H., Makela O. Maternal antibodies partly inhibit an active antibody response to routine tetanus toxoid immunization in infants. J Infect Dis 1992, 165(May (5)):977-979.
29. Englund J.A., Anderson E.L., Reed G.F., Decker M.D., Edwards K.M., Pichichero M.E., et al. The effect of maternal antibody on the serologic response and the incidence of adverse reactions after primary immunization with acellular and whole-cell pertussis vaccines combined with diphtheria and tetanus toxoids. Pediatrics 1995, 96(September (3 Pt. 2)):580-584.
30. Burstyn D.G., Baraff L.J., Peppler M.S., Leake R.D., St Geme J., Manclark C.R. Serological response to filamentous hemagglutinin and lymphocytosis-promoting toxin of Bordetella pertussis. Infect Immun 1983, 41(September (3)):1150-1156.
31. Baraff L.J., Leake R.D., Burstyn D.G., Payne T., Cody C.L., Manclark C.R., et al. Immunologic response to early and routine DTP immunization in infants. Pediatrics 1984, 73(January (1)):37-42.
32. Provenzano R.W., Wetterlow L.H., Sullivan C.L. Immunization and antibody response in the newborn infant. I. Pertussis inoculation within twenty-four hours of birth. N Engl J Med 1965, 273(October (18)):959-965.
33. Siegrist C.A. Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants. Vaccine 2003, 21(July (24)):3406-3412.
34. Siegrist C.A. The challenges of vaccine responses in early life: selected examples. J Comp Pathol 2007, 137(July (Suppl. 1)):S4-S9.
35. Heininger U., Cherry J.D., Christenson P.D., Eckhardt T., Goering U., Jakob P., et al. Comparative study of Lederle/Takeda acellular and Lederle whole-cell pertussis-component diphtheria-tetanus-pertussis vaccines in infants in Germany. Vaccine 1994, 12(January (1)):81-86.
36. Siegrist C.A. Neonatal and early life vaccinology. Vaccine 2001, 19(May (25-26)):3331-3346.
37. Siegrist C.A., Barrios C., Martinez X., Brandt C., Berney M., Cordova M., et al. Influence of maternal antibodies on vaccine responses: inhibition of antibody but not T cell responses allows successful early prime-boost strategies in mice. Eur J Immunol 1998, 28(December (12)):4138-4148.
38. Elahi S., Holmstrom J., Gerdts V. The benefits of using diverse animal models for studying pertussis. Trends Microbiol 2007, 15(October (10)):462-468.
39. Standfast A.F. The comparison between field trials and mouse protection tests against intranasal and intracerebral challenges with Bordetella pertussis. Immunology 1958, 1(April (2)):135-143.
40. Mills K.H., Brady M., Ryan E., Mahon B.P. A respiratory challenge model for infection with Bordetella pertussis: application in the assessment of pertussis vaccine potency and in defining the mechanism of protective immunity. Dev Biol Stand 1998, 95:31-41.
41. Guiso N., Capiau C., Carletti G., Poolman J., Hauser P. Intranasal murine model of Bordetella pertussis infection. I. Prediction of protection in human infants by acellular vaccines. Vaccine 1999, 17(May (19)):2366-2376.
42. Mills K.H. Immunity to Bordetella pertussis. Microbes Infect 2001, 3(July (8)):655-677.
43. Pittman M., Furman B.L., Wardlaw A.C. Bordetella pertussis respiratory tract infection in the mouse: pathophysiological responses. J Infect Dis 1980, 142(July (1)):56-66.
44. Elahi S., Brownlie R., Korzeniowski J., Buchanan R., O'Connor B., Peppler M.S., et al. Infection of newborn piglets with Bordetella pertussis: a new model for pertussis. Infect Immun 2005, 73(June (6)):3636-3645.
45. Elahi S., Buchanan R.M., Babiuk L.A., Gerdts V. Maternal immunity provides protection against pertussis in newborn piglets. Infect Immun 2006, 74(May (5)):2619-2627.
46. Rothkotter H.J., Sowa E., Pabst R. The pig as a model of developmental immunology. Hum Exp Toxicol 2002, 21(September-October (9-10)):533-536.
47. Goldman A.S. Evolution of the mammary gland defense system and the ontogeny of the immune system. J Mammary Gland Biol Neoplasia 2002, 7(July (3)):277-289.
48. Salmon H., Berri M., Gerdts V., Meurens F. Humoral and cellular factors of maternal immunity in swine. Dev Comp Immunol 2009, 33(March (3)):384-393.
49. Boersma W.J., Van Rooij E.M., Scholten J.W., Zwart R.J., Kimman T.G., Bianchi A. Silent memory induction in maternal immune young animals. Vet Q 1998, 20(Suppl. 3):S89-S92.
50. Rappuoli R. The vaccine containing recombinant pertussis toxin induces early and long-lasting protection. Biologicals 1999, 27(June (2)):99-102.
51. Roduit C., Bozzotti P., Mielcarek N., Lambert P.H., del Giudice G., Locht C., et al. Immunogenicity and protective efficacy of neonatal vaccination against Bordetella pertussis in a murine model: evidence for early control of pertussis. Infect Immun 2002, 70(July (7)):3521-3528.
52. Siegrist C.A. Vaccination in the neonatal period and early infancy. Int Rev Immunol 2000, 19(2-3):195-219.
53. Van Savage J., Decker M.D., Edwards K.M., Sell S.H., Karzon D.T. Natural history of pertussis antibody in the infant and effect on vaccine response. J Infect Dis 1990, 161(March (3)):487-492.
54. Belloni C., De Silvestri A., Tinelli C., Avanzini M.A., Marconi M., Strano F., et al. Immunogenicity of a three-component acellular pertussis vaccine administered at birth. Pediatrics 2003, 111(May (5 Pt. 1)):1042-1045.
55. Heron I., Chen F.M., Fusco J. DTaP vaccines from North American vaccine (NAVA): composition and critical parameters. Biologicals 1999, 27(June (2)):91-96.
56. Ibsen P.H. The effect of formaldehyde, hydrogen peroxide and genetic detoxification of pertussis toxin on epitope recognition by murine monoclonal antibodies. Vaccine 1996, 14(April (5)):359-368.
57. Murphy T.V., Slade B.A., Broder K.R., Kretsinger K., Tiwari T., Joyce P.M., et al. Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2008, 57(May (RR-4)):1-51.
58. Oda M., Izumiya K., Sato Y., Hirayama M. Transplacental and transcolostral immunity to pertussis in a mouse model using acellular pertussis vaccine. J Infect Dis 1983, 148(July (1)):138-145.
59. Sato H., Sato Y. Protective antigens of Bordetella pertussis mouse-protection test against intracerebral and aerosol challenge of B. pertussis. Dev Biol Stand 1985, 61:461-467.